myopia

Mar 18, 2025

FDA Expands SOLIRIS for Pediatric Myasthenia Gravis; vTv’s Cadisegliatin Program Resumes as FDA Lifts Hold; ENCell’s EN001 Wins Orphan Drug Designation for Charcot-Marie-Tooth; FDA Accepts Sydnexis’ NDA for SYD-101 in Pediatric Myopia; Cambium Bio’s Potency Assay Strategy Cleared for Elate Ocular Phase III Trials

Aug 23, 2023

Contact Lenses: A Comprehensive Guide to Vision Correction and Beyond

Jan 04, 2023

Insights Into the Evolving Landscape of the Ocular Implants Market

May 12, 2022

Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit

Jun 16, 2021

How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market

Newsletter/Whitepaper